Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin delivery
Conclusions: Delivery of granulysin by recombinant adenovirus to the infected lung could enhance the clearance of TB in vivo and might be a promising adjunct therapeutic vaccine for TB and MDR-TB.
Source: Theranostics - Category: Molecular Biology Authors: Ling Hao, Jilei Ma, Chunwei Shi, Xiaosong Lin, Yandi Zhang, Banga Ndzouboukou Jo-Lewis, Qing Lei, Nadeem Ullah, Zhongjie Yao, Xionglin Fan Tags: Research Paper Source Type: research
More News: Adenoviruses | Chemotherapy | Immunotherapy | Infectious Diseases | Molecular Biology | Multidrug Resistance | Parasitology | Tuberculosis | Vaccines